Dysregulated ADAM10-mediated processing of APP during a critical time window leads to synaptic deficits in Fragile X syndrome

The Fragile X mental retardation protein (FMRP) regulates neuronal RNA metabolism, and its absence or mutations leads to the Fragile X syndrome (FXS). The β-amyloid precursor protein (APP) is involved in Alzheimer’s disease, plays a role in synapse formation, and is upregulated in intellectual disab...

Full description

Saved in:
Bibliographic Details
Main Authors: Pasciuto, Emanuela (Author) , Ahmed, Tariq (Author) , Wahle, Tina (Author) , Gardoni, Fabrizio (Author) , D’Andrea, Laura (Author) , Pacini, Laura (Author) , Jacquemont, Sébastien (Author) , Tassone, Flora (Author) , Balschun, Detlef (Author) , Dotti, Carlos G. (Author) , Callaerts-Vegh, Zsuzsanna (Author) , D’Hooge, Rudi (Author) , Müller, Ulrike C. (Author) , Di Luca, Monica (Author) , De Strooper, Bart (Author) , Bagni, Claudia (Author)
Format: Article (Journal)
Language:English
Published: July 15, 2015
In: Neuron
Year: 2015, Volume: 87, Issue: 2, Pages: 382-398
ISSN:1097-4199
DOI:10.1016/j.neuron.2015.06.032
Online Access:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1016/j.neuron.2015.06.032
Verlag, lizenzpflichtig, Volltext: http://www.sciencedirect.com/science/article/pii/S0896627315005954
Get full text
Author Notes:Emanuela Pasciuto, Tariq Ahmed, Tina Wahle, Fabrizio Gardoni, Laura D’Andrea, Laura Pacini, Sébastien Jacquemont, Flora Tassone, Detlef Balschun, Carlos G. Dotti, Zsuzsanna Callaerts-Vegh, Rudi D’Hooge, Ulrike C. Müller, Monica Di Luca, Bart De Strooper, and Claudia Bagni
Description
Summary:The Fragile X mental retardation protein (FMRP) regulates neuronal RNA metabolism, and its absence or mutations leads to the Fragile X syndrome (FXS). The β-amyloid precursor protein (APP) is involved in Alzheimer’s disease, plays a role in synapse formation, and is upregulated in intellectual disabilities. Here, we show that during mouse synaptogenesis and in human FXS fibroblasts, a dual dysregulation of APP and the α-secretase ADAM10 leads to the production of an excess of soluble APPα (sAPPα). In FXS, sAPPα signals through the metabotropic receptor that, activating the MAP kinase pathway, leads to synaptic and behavioral deficits. Modulation of ADAM10 activity in FXS reduces sAPPα levels, restoring translational control, synaptic morphology, and behavioral plasticity. Thus, proper control of ADAM10-mediated APP processing during a specific developmental postnatal stage is crucial for healthy spine formation and function(s). Downregulation of ADAM10 activity at synapses may be an effective strategy for ameliorating FXS phenotypes.
Item Description:Gesehen am 01.07.2020
Physical Description:Online Resource
ISSN:1097-4199
DOI:10.1016/j.neuron.2015.06.032